John D. Halpern 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 9:13 pm Purchase | 2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA | John D. Halpern | 398,122 9.600% | 55,683 (+16.26%) | Filing |
| 2025-02-14 8:36 pm Purchase | 2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA | John D. Halpern | 342,439 9.990% | 342,439 (New Position) | Filing |